Immix Biopharma, Inc. IMMX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $79.25M-15.6% | $93.93M+489% | $15.95M+37.0% | $11.64M-26.9% | $15.92M-10.0% | ||
| $11.33M+74.8% | $6.48M— | —— | —— | —— | ||
| $92.27M-8.9% | $101.24M+510% | $16.58M+34.6% | $12.33M-26.5% | $16.78M-16.9% | ||
| $2.43M-3.7% | $2.52M+6.9% | $2.36M+5.7% | $2.23M+5.1% | $2.12M+22.1% | ||
| $95.82M-8.6% | $104.84M+422% | $20.08M+28.4% | $15.64M-21.4% | $19.89M-13.3% | ||
| $4.73M-13.1% | $5.44M-22.8% | $7.05M+6.6% | $6.61M+15.2% | $5.74M+6.6% | ||
| $10.54M+4.2% | $10.11M-6.8% | $10.85M+8.4% | $10.01M+7.5% | $9.31M+7.1% | ||
| $11.45M+3.7% | $11.04M-6.5% | $11.82M+7.6% | $10.98M+6.6% | $10.3M— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$114.55M-9.7% | -$104.46M-11.4% | -$93.78M-8.8% | -$86.19M-8.3% | -$79.57M-6.1% | ||
| $84.36M-10.1% | $93.8M+1,035% | $8.26M+77.6% | $4.65M-51.5% | $9.59M-27.6% | ||
| $95.82M-8.6% | $104.84M+422% | $20.08M+28.4% | $15.64M-21.4% | $19.89M-13.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Immix Biopharma, Inc.'s total assets?
- Immix Biopharma, Inc. (IMMX) holds $95.8M in total assets, up 381.7% year over year.
- How much debt does Immix Biopharma, Inc. have?
- Immix Biopharma, Inc. carries $1.0M in total debt against $84.4M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Immix Biopharma, Inc. have?
- Immix Biopharma, Inc. holds $79.3M in cash and equivalents.
- Can Immix Biopharma, Inc. cover its short-term obligations?
- Its current ratio is 8.76 — current assets exceed current liabilities.
- Where does Immix Biopharma, Inc.'s balance sheet data come from?
- Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.